Skip to main content
. Author manuscript; available in PMC: 2015 May 1.
Published in final edited form as: Cancer Lett. 2014 Jan 29;346(2):217–224. doi: 10.1016/j.canlet.2014.01.021

Table 1.

Molecular targets of sulindac sulfide and tolfenamic acid in different cancer types.

NSAIDs Up-
regulated
targets
Down-
regulated
targets
Cancer types [References]
Sulindac sulfide EGR-1 Colon [80], Lung [13], brain [95]
ATF3 Colon [20]
NF-κB Colon [46], Breast [96]
NF-κB Colon [50]
β-catenin Colon [53], lung and breast [97]
EGFR Colon [61]
E-cadherin Colon [63]
PDE5 Colon [67]
NAG-1 Colon [74], ovarian [78], Gastric [98], Prostate [99]
Nesprin-2 Colon [73]
p21 Breast [92], ovarian [78], Head/Neck [100], Pancreas [101]
CHOP Colon [28]
Cyclin D1 Breast [92], pancreas [101], colon [102]
Tolfenamic acid EGR-1 Colon [15]
ATF3 Colon [19]
ATF4 Colon [9]
CHOP Colon [9]
Sp1 Pancreas [36], Rhabdomyosarcoma [37], lung [38], esophageal [91]. Ovarian [103], colon [40]
NF-κB Colon [49]
Smad2/3 Lung [60]
NAG-1 Colon [15], Oral [76], thyroid [79]
p21 Breast [104]
Cyclin D1 Colon [9]